360° SearchNetwork Hot Spots Trends Time Series

Leland Wilson

Type: Person

Name: Leland Wilson

First reported May 13 2013 - Updated May 13 2013 - 2 reports

Vivus Adds Two New Directors to Board Amid Shareholder Pressure

Vivus Inc. (VVUS)J. Martin Carroll and Jorge Plutzky joined the board, the Mountain View, California-based drugmaker said in a statement today. On April 30, the company said it appointed Robert N. Wilson. The additions bring the size of Vivus’s board ... [Published BusinessWeek - May 13 2013]

Entities: Vivus Inc, Qsymia, Leland Wilson, QVT, Manhattan

First reported May 10 2013 - Updated May 10 2013 - 1 reports

Vivus plans drug tie-up with large pharma firms

NEW YORK: Vivus has said it has begun talks with large pharmaceutical companies to accelerate the marketing of its diet pill after coming under pressure from hostile investors over slow initial sales, sending its shares up 7 per cent.After reporting weak ... [Published The Gulf Today - May 10 2013]

Entities: Qsymia, Drugs, Leland Wilson, Diet

First reported May 09 2013 - Updated May 09 2013 - 1 reports

After going it alone, Vivus finally open to Big Pharma sales partnership

Qsymia needs help to compete with BelviqShareToolsWhen Vivus ($VVUS) announced first-quarter earnings yesterday, sales weren't just off of analyst estimates. They also crushed investors' hopes that the company could halt its continued failure to get its ... [Published FiercePharma - May 09 2013]

Entities: Vivus Inc, Qsymia, Big Pharma

First reported May 08 2013 - Updated May 09 2013 - 4 reports

Obesity Battle Heats Up as VIVUS, Inc. Talks to Partners

Vivus Inc. (VVUS), maker of the obesity drug Qsymia, said itâs in talks with large pharmaceutical companies to explore ways to increase use of the medicine amid investor unrest over disappointing sales. The shares rose the most in five months. Approved ... [Published BioSpace - May 09 2013]

Entities: Vivus Inc, Obesity, Qsymia

First reported May 08 2013 - Updated May 08 2013 - 3 reports

Vivus in Talks With Potential Partners, CEO Says

(Corrects spelling of Qsymia in fourth and fifth paragraphs.)May 8 (Bloomberg) -- Vivus Inc., maker of the obesity drug Qsymia, is in talks with large pharmaceutical companies to explore ways to increase sales of the medicine, which have disappointed ... [Published Washington Post - May 08 2013]

Entities: Vivus Inc, Qsymia, Leland Wilson, Obesity

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Arena Pharmaceuticals Inc

VIVUS, Inc. (VVUS) Pops as Larger Qsymia Retail Presence Expected Soon

VIVUS, Inc. (Nasdaq: VVUS) shares are ripping following Q1 results reported earlier. However, he move might be tied to more than just the numbers.Ahead of the bell Wednesday, VIVUS reported a loss of 53 cents on revs of $4.1 million, both missing consensus ... [Published Street Insider - May 08 2013]

Entities: Vivus Inc, Qsymia, Leland Wilson, Arena Pharmaceuticals Inc

First reported May 07 2013 - Updated May 08 2013 - 1 reports

AstraZeneca PLC

Former AstraZeneca N.A. CEO to Serve as Senior Advisor to VIVUS (VVUS)

Vivus, Inc. (Nasdaq: VVUS) announced that Richard Fante, former president U.S., CEO North America and regional vice president Americas at AstraZeneca (NYSE: AZN), has agreed to provide advisory services to the Company. In this role, Mr. Fante will advise ... [Published Street Insider - May 07 2013]

Entities: Vivus Inc, AstraZeneca PLC, Qsymia

First reported Feb 26 2013 - Updated Feb 26 2013 - 1 reports

VIVUS Earnings: Here’s Why Investors were Disappointed

VIVUS Inc. ( NASDAQ:VVUS ) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. These stocks are hitting ... [Published Wall St. Cheat Sheet - Feb 26 2013]

Entities: Vivus Inc, Qsymia, Leland Wilson, Xignite Financials, Earnings Per Share

First reported Feb 26 2013 - Updated Feb 26 2013 - 1 reports

Vivus CEO Discusses Q4 2012 Results - Earnings Call Transcript

Vivus ( VVUS ) Q4 2012 Results Earnings Call February 25, 2013 4:30 p.m. ET Executives Timothy Morris - CFO Leland Wilson - CEO Michael Miller - Chief Commercial Officer and Senior Vice President Peter Tam - President and Director Analysts ... [Published Transcripts from Seeking Alpha - Feb 26 2013]

Entities: Vivus Inc, Tim Morris, Leland Wilson, Marko Kozul

More Content

sort by: Date \| Relevance
Alex Denner Joins Vivus Activist Slate in First... [Published BusinessWeek - 11 hours ago]
Vivus Adds Two New Directors to Board Amid Shar... [Published BusinessWeek - May 13 2013]
Vivus Adds Two New Directors to Board Amid Pres... [Published Bloomberg - May 13 2013]
Vivus plans drug tie-up with large pharma firms [Published The Gulf Today - May 10 2013]
After going it alone, Vivus finally open to Big... [Published FiercePharma - May 09 2013]
Obesity Battle Heats Up as VIVUS, Inc. Talks to... [Published BioSpace - May 09 2013]
Obesity battle hots up as Vivus talks to partners [Published Pharma Times - May 09 2013]
Vivus, Obesity Drug Stocks Finally Get Some… [Published Investors Business Daily - May 09 2013]
Vivus, Obesity Drug Stocks Finally Get Some Goo... [Published Investors Business Daily - May 08 2013]
Vivus in Talks With Potential Marketing Partner... [Published Washington Post - May 08 2013]
Vivus in Talks With Potential Partners, CEO Says [Published Washington Post - May 08 2013]
Vivus in Talks With Potential Marketing Partner... [Published BusinessWeek - May 08 2013]
VIVUS, Inc. (VVUS) Pops as Larger Qsymia Retail... [Published Street Insider - May 08 2013]
Vivus in Talks With Potential Marketing Partner... [Published Bloomberg - May 08 2013]
Vivus' CEO Discusses Q1 2013 Results - Earnings... [Published Seeking Alpha - May 08 2013]
VIVUS Reports First Quarter 2013 Financial Results [Published Street Insider - May 08 2013]
Former AstraZeneca N.A. CEO to Serve as Senior ... [Published Street Insider - May 07 2013]
VIVUS Announces Richard Fante, Former President... [Published Morningstar.com - May 07 2013]
VIVUS Earnings: Here’s Why Investors are Not Ex... [Published Wall St. Cheat Sheet - Feb 26 2013]
VIVUS Earnings: Here’s Why Investors were Disap... [Published Wall St. Cheat Sheet - Feb 26 2013]
Vivus CEO Discusses Q4 2012 Results - Earnings ... [Published Transcripts from Seeking Alpha - Feb 26 2013]
VIVUS to Present at the 2013 JP Morgan Healthca... [Published GlobeNewswire: Advertising News - Jan 04 2013]
Is Vivus’s Stock a Buy After This News From Aetna? [Published Wall St. Cheat Sheet - Nov 25 2012]

Blogs

sort by: Date \| Relevance
VIVUS Earnings: Here’s Why Investors are Not Ex... [Published Wall St. Cheat Sheet - Feb 26 2013] VIVUS Inc. ( NASDAQ:VVUS ) had a loss and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are down 7%. These stocks ...
VIVUS Earnings: Here’s Why Investors were Disap... [Published Wall St. Cheat Sheet - Feb 26 2013] VIVUS Inc. ( NASDAQ:VVUS ) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. These stocks are hitting ...
Is Vivus’s Stock a Buy After This News From Aetna? [Published Wall St. Cheat Sheet - Nov 25 2012] With shares of Vivus ( NASDAQ:VVUS ) now trading just below $12, is VVUS a BUY, a WAIT and SEE, or a STAY AWAY? Let’s analyze the stock with the relevant sections of our CHEAT SHEET investing framework : C = Catalyst for the Stock’s Movement: ...

Press Releases

sort by: Date \| Relevance
VIVUS to Present at the 2013 JP Morgan Healthca... [Published GlobeNewswire: Advertising News - Jan 04 2013]